UNSPSC 51143902: Cathine or norpseudoephedrine

This classification denotes an alkaloid with the molecular formula C9H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E1L4ZW2F8O, chemically known as (r*,s*)-(1)-alpha-(1-aminoethyl)benzyl alcohol but more generally known as cathine, which bears US NIH Compound Identifier 26934. Cathine most often comes in base and hydrochloride forms. European Medicines Agency schedules Cathine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06158MIG. The term CATHINE is an International Non-Proprietary Name.

UNSPSC 51143902 Cathine or norpseudoephedrine is a Commodity code that, based on recent state and local solicitations, does not align with actual procurement activity under this classification. The three most recent opportunities posted under or near this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, and generic multi-source pharmaceuticals and OTC products — none of which match the specific chemical compound named in the code. State and local health and human services agencies, cooperative purchasing alliances, and county health departments are the primary issuing bodies pursuing pharmaceutical procurement, but the work being solicited spans broad pharmacy benefit management, prescription fulfillment, and emergency medical countermeasure supply chains rather than a single controlled or specialty chemical product. The mismatch suggests either systematic tagging error or that this code is rarely or incorrectly applied in state and local procurement.

Recent opportunities span Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response deadline July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program supporting self-insured pharmacy benefit plans. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code shows little relevant recent activity under its stated scope.